Jay Lichter, Director, 10% Owner at Janux Therapeutics, Inc. (JANX), sold 2,868,804 shares at $54.75 ($157.1M) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Open-market sale of $157.1M JANX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.75 | 131,196 | $7.2M | 4.6% |
| 2 | $54.75 | 677,279 | $37.1M | 23.6% |
| 3 | $54.75 | 677,279 | $37.1M | 23.6% |
| 4 | $54.75 | 691,525 | $37.9M | 24.1% |
| 5 | $54.75 | 691,525 | $37.9M | 24.1% |
| Total | $54.75 avg |
| 2,868,804 |
| $157.1M |
| 100% |
| Filing → |
| JANX | BUY | 2021-06-16 | $10.7M | — | Filing → |
| OTIC | SELL | 2021-03-03 | $1.7M | — | Filing → |
| OTIC | SELL | 2021-03-02 | $5.1M | — | Filing → |